| Literature DB >> 26353965 |
Vidyanath Chaudhary1, Shuo Zhang2, Kit-San Yuen1, Chuan Li2, Pak-Yin Lui1, Sin-Yee Fung1, Pei-Hui Wang1, Chi-Ping Chan1, Dexin Li2, Kin-Hang Kok3, Mifang Liang2, Dong-Yan Jin1.
Abstract
Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen causing significant morbidity and mortality in Asia. NSs protein of SFTSV is known to perturb type I IFN induction and signalling, but the mechanism remains to be fully understood. Here, we showed the suppression of both type I and type III IFN signalling by SFTSV NSs protein is mediated through inhibition of STAT1 phosphorylation and activation. Infection with live SFTSV or expression of NSs potently suppressed IFN-stimulated genes but not NFkB activation. NSs was capable of counteracting the activity of IFN-α1, IFN-β, IFN-λ1 and IFN-λ2. Mechanistically, NSs associated with STAT1 and STAT2, mitigated IFN-β-induced phosphorylation of STAT1 at S727, and reduced the expression and activity of STAT1 protein in IFN-β-treated cells, resulting in the inhibition of STAT1 and STAT2 recruitment to IFNstimulated promoters. Taken together, SFTSV NSs protein is an IFN antagonist that suppresses phosphorylation and activation of STAT1.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26353965 DOI: 10.1099/jgv.0.000280
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891